Anumana

Decision/Risk Analysis · Cambridge, MA · Founded 2021 · Privately Held (backing)

Developer of an AI-driven medical technology designed to enhance early diagnosis and intervention in cardiovascular care. Anumana is based in Cambridge, MA and was founded in 2021. It was valued at $580 million at its early-stage round in Mar 2025, the last priced event on record. It has raised $185 million across 3 recorded rounds; the latest was a $95.4 million early-stage round in Mar 2025.

PMV mark · valuation
$580.0M
Oct 2026
Priced at
its early-stage round
Mar 2025
Total raised
$185.3M
Last round
Early Stage VC
Mar 2025
Cap table — not yet on record

Anumana's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Anumana with a free account
  • ·Watch Anumana: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Frequently asked about Anumana

Where does Anumana's cap table come from?
Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Anumana's 3 recorded funding rounds.